CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-07-10): Statins may hold promise for chronic hepatitis C infection

Drug & Device Development

Statins may hold promise for chronic hepatitis C infection

Last Updated: 2006-07-10 16:54:08 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Findings from a new study indicate that statins, particularly fluvastatin, can inhibit the replication of hepatitis C virus (HCV). As such, these drugs may serve as a useful adjunct to interferon therapy, the authors conclude.

Dr. Nobuyuki Kato, from Okayama University Graduate School of Medicine in Japan, and colleagues note that while interferon plus ribavirin is the current treatment of choice for HCV infection, it is only effective in about 55% of patients. Thus, there is a need for new therapies.

Recent reports have described an anti-HCV effect of lovastatin. In the present study, reported in the July issue of Hepatology, the researchers used an HCV replication assay they had created, called OR6, to evaluate the effects of several statins alone or in combination with pegylated interferon.

As noted, fluvastatin showed the strongest anti-HCV activity. Atorvastatin and simvastatin had the next strongest effects followed by lovastatin. Pravastatin, by contrast, displayed no anti-HCV activity. Adding mevalonate or geranylgeraniol reversed the anti-HCV effects.

"The results of the present study suggest that statins other than pravastatin are good reagents for combination therapy with interferon-gamma in patients with chronic hepatitis C," the researchers conclude.

Hepatology 2006;44:117-125.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.